stem-cell-therapy-market-in-apac-to-be-worth-usd972-million-in-2018

APAC stem cell therapy market to reach $972mn in 2018

  • Singapore
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: A new study by Reports and Reports predicted that the stem cell therapy market in Asia Pacific (APAC) will grow in value from $545 million in 2012 to... Read more

license-agreement-yuhan-to-use-cevec-cap-t-technology

CEVEC signs deal with Yuhan in South Korea

  • Korea
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: CEVEC Pharmaceuticals, the developer of a novel human expression system derived from amniocytes, and Yuhan Corporation, a leading manufacturer of pharmaceutical... Read more

astrazeneca-legochem-collaborate-to-develop-antibiotic-resistant-bacterial-infections-drug

AstraZeneca, LegoChem drug to curb superbugs

  • Korea
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: AstraZeneca has formed collaboration with Korea's LegoChem Biosciences to develop a novel antibiotic to treat drug-resistant bacterial infections. The... Read more

cevec-pharmaceuticals-yuhan-sign-cap-technology-license-agreement

CEVEC, Yuhan sign deal for immortalized cell lines

  • Korea
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: CEVEC Pharmaceuticals, the developer of a novel human expression system derived from amniocytes, and Yuhan, a leading manufacturer of pharmaceutical... Read more

Biotech-310x175_copy

ASKLEP joins Medidata partner program

  • Japan
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: ASKLEP, a leading Tokyo-based provider of clinical research services, has joined the Medidata Solutions Partner Program as part of its strategy to expand... Read more

quintiles-signs-bioanalytical-deal-with-korean-cro

Quintiles signs bioanalytical deal with Korean CRO

  • Korea
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: To enhance its bioanalytical service offerings in Asia, Quintiles has signed an exclusive partnership with BioCore, a leading Seoul-based bioanalytical... Read more

profit-from-the-jv-will-be-split-51-percent-and-49-percent-between-teva-and-handok-respectively

Teva enters Korean pharmaceutical market

  • Korea
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Israel-based Teva Pharmaceutical and Korea's Handok Pharmaceuticals will establish a business venture in South Korea, allowing Teva to gain entrance into... Read more

heartbeat-experts-expands-its-presence-in-brazil-russia-india-china-and-korea-brick

Heartbeat Experts expands in BRICK

  • India
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Heartbeat Experts, the global leader in stakeholder management solutions for the life sciences industry, announced increased revenue and expansion of... Read more

frost-sullivan-medical-devices-distributors-in-vietnam-indonesia-thailand-and-south-korea-are-highly-fragmented

F&S: Medical devices market highly fragmented

  • Indonesia
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: A new analysis from Frost & Sullivan, titled Medical Devices Distributor Profiling in Vietnam, Indonesia, Thailand and South Korea (VITSK), revealed that... Read more

Special Features

Survey Box

Ranbaxy Controversy

Will the Ranbaxy controversy end the Indian pharma dominion in the US market?

Send this article by email

X